|
ZBTB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.242000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.280600E-01 |
| Normal-vs-Stage2 |
4.265000E-01 |
| Normal-vs-Stage3 |
5.433200E-01 |
| Normal-vs-Stage4 |
7.024600E-01 |
| Stage1-vs-Stage2 |
2.348600E-01 |
| Stage1-vs-Stage3 |
2.747200E-01 |
| Stage1-vs-Stage4 |
4.630400E-01 |
| Stage2-vs-Stage3 |
7.171200E-01 |
| Stage2-vs-Stage4 |
6.254200E-01 |
| Stage3-vs-Stage4 |
8.510600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.497800E-01 |
| Normal-vs-AfricanAmerican |
4.784100E-02 |
| Normal-vs-Asian |
6.250800E-01 |
| Caucasian-vs-AfricanAmerican |
3.439700E-02 |
| Caucasian-vs-Asian |
6.938800E-01 |
| AfricanAmerican-vs-Asian |
2.052200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.127600E-01 |
| Normal-vs-Female |
4.162600E-01 |
| Male-vs-Female |
4.326400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.041600E-02 |
| Normal-vs-Age(41-60Yrs) |
8.994800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.545800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.640400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.286360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.486000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.376600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.022200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.257000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.585800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.378000E-02 |
| Normal-vs-Grade 2 |
2.270200E-01 |
| Normal-vs-Grade 3 |
1.100550E-01 |
| Normal-vs-Grade 4 |
7.151600E-01 |
| Grade 1-vs-Grade 2 |
3.694600E-01 |
| Grade 1-vs-Grade 3 |
1.782050E-02 |
| Grade 1-vs-Grade 4 |
1.586440E-01 |
| Grade 2-vs-Grade 3 |
3.809300E-04 |
| Grade 2-vs-Grade 4 |
1.584420E-01 |
| Grade 3-vs-Grade 4 |
3.603200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.985900E-02 |
| Normal-vs-ccB subtype |
3.307800E-02 |
| ccA subtype-vs-ccB subtype |
2.34080000049985E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.363800E-01 |
| Normal-vs-N1 |
7.423800E-01 |
| N0-vs-N1 |
7.346200E-01 |
|
|
